Co-Authors
This is a "connection" page, showing publications co-authored by Jan Münch and Konstantin Sparrer.
Connection Strength
1.040
-
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities. Cell Rep. 2021 05 18; 35(7):109126.
Score: 0.236
-
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nat Commun. 2021 03 19; 12(1):1726.
Score: 0.234
-
Supramolecular Mechanism of Viral Envelope Disruption by Molecular Tweezers. J Am Chem Soc. 2020 10 07; 142(40):17024-17038.
Score: 0.226
-
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat Commun. 2021 07 28; 12(1):4584.
Score: 0.060
-
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021 02; 3(2):149-165.
Score: 0.058
-
Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal Organoids. Cell Mol Gastroenterol Hepatol. 2021; 11(4):935-948.
Score: 0.057
-
SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans. mBio. 2020 10 16; 11(5).
Score: 0.057
-
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19. Clin Med (Lond). 2020 11; 20(6):e218-e221.
Score: 0.056
-
An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection. Antiviral Res. 2020 09; 181:104882.
Score: 0.056